Nykredit A S bought a new position in Xylem Inc. (NYSE:XYL – Free Report) in the second quarter, according to its most recent filing with the SEC. The firm bought 99,549 shares of the industrial products company’s stock, valued at approximately $11,768,000.
A number of other hedge funds have also bought and sold shares of the stock. Thrive Wealth Management LLC lifted its stake in shares of Xylem by 2.1% during the second quarter. Thrive Wealth Management LLC now owns 5,032 shares of the industrial products company’s stock worth $595,000 after buying an additional 104 shares during the period. Coppell Advisory Solutions LLC acquired a new position in shares of Xylem in the 2nd quarter valued at $659,000. Nwam LLC raised its stake in Xylem by 62.2% in the 2nd quarter. Nwam LLC now owns 16,728 shares of the industrial products company’s stock worth $1,977,000 after acquiring an additional 6,415 shares during the last quarter. Two Sigma Securities LLC lifted its position in Xylem by 34.8% during the 2nd quarter. Two Sigma Securities LLC now owns 11,316 shares of the industrial products company’s stock worth $1,338,000 after acquiring an additional 2,919 shares during the period. Finally, GTS Securities LLC acquired a new stake in Xylem during the 2nd quarter worth about $268,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Stock Performance
XYL opened at $105.91 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24. The firm has a fifty day moving average price of $117.60 and a 200 day moving average price of $118.08. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The stock has a market cap of $24.73 billion, a P/E ratio of 25.22, a P/E/G ratio of 1.73 and a beta of 1.00.
Xylem Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Thursday, August 27th. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. Xylem’s dividend payout ratio is presently 40.95%.
Analysts Set New Price Targets
A number of research firms recently commented on XYL. Mizuho lifted their target price on Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Jefferies Financial Group lifted their price objective on shares of Xylem from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, August 24th. Barclays increased their price objective on shares of Xylem from $154.00 to $159.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. Citigroup restated a “buy” rating on shares of Xylem in a research report on Wednesday, July 29th. Finally, UBS Group increased their price target on Xylem from $135.00 to $138.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. Nine equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.
Check Out Our Latest Analysis on XYL
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
